State Street
ENZY

State Street’s Enzymotec Ltd ENZY Stock Holding History

State Street’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-20,952
Closed -$169K – 3773
2017
Q2 		$169K Buy
20,952
+380
+2% +$3.17K ﹤0.01% 3539
2017
Q1 		$181K Buy
20,572
+628
+3% +$5.32K ﹤0.01% 3511
2016
Q4 		$131K Buy
19,944
+890
+5% +$5.86K ﹤0.01% 3520
2016
Q3 		$134K Buy
+19,054
New +$153K ﹤0.01% 3428

Other funds holding ENZY

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
MC
Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street's ENZY Position: Q3 2017 in Review

State Street sold out of Enzymotec Ltd (ENZY) in Q3 2017, closing a stake of 20,952 shares — an estimated $169K sold.

State Street first reported a position in ENZY in Q3 2016 and held it in 4 quarters. The position peaked at $181K in Q1 2017. 20 funds tracked by Wall St. Rank hold ENZY as of Q3 2017.

  • State Street reported no remaining Enzymotec Ltd position as of Q3 2017 after selling out during the quarter.
  • State Street sold 20,952 Enzymotec Ltd shares in Q3 2017, an estimated $169K.
  • State Street first reported a position in Enzymotec Ltd in Q3 2016 and held it in 4 quarters.
  • State Street's Enzymotec Ltd position peaked at $181K in Q1 2017.
  • 20 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q3 2017.

Based on State Street's 13F filing for Q3 2017, filed 14 Nov 2017.